Delivery Order SPE2DB22D1002-SPE2DB25FKYW2

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,076.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a medical supply product, with a completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award, valued at $8,153.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a specialty medication, with a period of performance through November 16, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $17,126.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is a delivery order placed with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for TRESIBA FLEXTOUCH 100 UNIT/ML 3ML. The contract has a firm fixed price of $2,782.23 and a completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award, valued at $3,737.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,520.65, is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a specialty medication. This is a Firm Fixed Price Delivery Order contract with a period of performance extending through November 29, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,201.32 firm-fixed-price delivery order is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,321.84 and is a delivery order for the procurement of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a medication used for diabetes management. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a specialty medication, with a ceiling value of $36,823.65. The contract has a firm fixed price and an ultimate completion date of January 5, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award, valued at $1,038.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a specialized pharmaceutical product. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKYW2
    Delivery Order

This federal contract award, valued at $3,873.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a medical product, and has a completion date of March 4, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/2/25, 10:00 AM